AIER Eye Hospital Group is a leading ophthalmic medical group (eye-care service provider) with domestic and global footprint and high-standard medical care capacity, serving patients across Asia, Europe, and North America. AIER has three public-trading companies listed in China, Europe, and Southeast Asia, respectively (Shenzhen Stock Market: AIER, 300015; Spain BME: CBAV; Singapore SGX: 40T). We have so far established 720 ophthalmic hospitals and centers across the world, including 611 hospitals and centers in mainland China, 7 in Hong Kong, China, 1 in the United States, 90 in Europe, and 12 in Southeast Asia. In 2020, we served more than 10 million outpatient visits and preformed over 1 million surgeries in mainland China. Our medical service network covers approximately 3 billion people worldwide.

Domestic market is the core business of AIER and international market plays a more and more important role in our global strategy. We are committed to introducing and absorbing the cutting-edge technology and advanced management concepts, as well as to contributing to the evolution of China's ophthalmology market, in a specialized, scaled-up and scientific way.

Through the past 19-year growth and expansion, AIER has attracted and cultivated a group of experienced management team with innovative spirit, as well as a team of well-trained ophthalmologists and doctors with excellent medical skills and rigorous scholarship. At present, AIER has more than 50,000 employees worldwide. Among them, 9,000 are ophthalmologists and optometrists (including domestic and overseas), with a big group of doctoral supervisors, master supervisors, doctors, post-doctors, oversea scholars, and even core experts with extensive clinical experiences.

AIER vigorously support the development of original and cutting-edge scientific research and make ourselves committed to creating a closed-loop ophthalmic ecosystem on a global platform by gradually increasing investment. In 2021, in response to the Preferential Strategy, to share global ophthalmic wisdom and to seize the opportunity of the construction of Hainan Free Trade Port, AIER laid out an "International Clinical Research Center" in Boao International Medical Tourism Pilot Zone to build Aier Eye Hospital of BoAo Hope City. In April 2021, Aier Eye Hospital of BoAo Hope City, witnessed by the leadership of the Hainan Provincial Party Committee and Provincial Government, signed an admission agreement with the Boao International Medical Tourism Pilot Zone Administration and started preparations for construction. On December 18, 2021, Aier Eye Hospital of BoAo Hope City，which is also an "International Clinical Research Center" officially held the opening ceremony in Boao Lecheng. Aier Eye Hospital of BoAo Hope City is not only the landing of AIER's "hierarchical chain" in Hainan, but also the "pioneering area" and "innovation base" of AIER.

AIER will carry out high-end ophthalmic medical services with the help of preferential policy of the Lecheng, and strive to build an international clinical research base integrating clinical, teaching, scientific research and innovation incubation. By providing and using new drugs, new devices and new equipment newly approved overseas for patients, Aier will accumulate experience for the comprehensive application of innovative drugs and devices in China, and build the hospital into a "international and domestic ophthalmic resource dual-circulation intersection".

Aier Eye Hospital of BoAo Hope City will cooperate with well-known ophthalmology experts, academic leaders, scientific research talents, as well as AIER's overseas doctor team and global partners to conduct multi-point practice in the hospital, thereby attracting more ophthalmic talents at home and abroad Join to build an ophthalmic diagnosis and treatment service system in line with international standards. At the same time, the hospital will continue to conduct clinical research in various fields such as refraction, optometry, cataract, glaucoma, fundus disease, keratoconus, orbital disease, etc., to build the hospital into an international treatment center as well as a base for teaching and training, and to promote advancement of human ophthalmology and visual science in China and the world.

As the first international clinical research center of AIER, Aier Eye Hospital of BoAo Hope City brings together world-renowned ophthalmology experts, unites international first-class ophthalmology institutions and product innovation manufacturers, and is committed to introducing the world's top medical resources to build a model of global ophthalmic medical center with the latest technology, the best service and experience at home and abroad. AIER's strategic goal is to continuously improve ophthalmic medical technology in China and to be recognized as world-level excellence by building up world-class and national-level ophthalmic medical center.